<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="herb has been employed in clinical practice for treatment of" exact="virus infection" post="and inflammation. However, its active ingredients remain unclear. Aim"/>
 <result pre="has been employed in clinical practice for treatment of virus" exact="infection" post="and inflammation. However, its active ingredients remain unclear. Aim"/>
 <result pre="epigoitrinÂ &amp;gt;Â epiprogoitrin. The attachment of the constituents to the" exact="viral" post="envelope conduced to the mechanism of their antiviral action"/>
 <result pre="conduced to the mechanism of their antiviral action without disturbing" exact="viral" post="adsorption or budding. Conclusion Taken together, these results are"/>
 <result pre="Radix and may contribute an adjunct to pharmacotherapy for influenza" exact="virus infection." post="Graphical abstract Keywords Influenza Antivirals Glucosinolate Isomer Isatidis Radix"/>
 <result pre="Dulbecco's Modified Eagle Medium DMSO dimethyl sulfoxide EID50 50% egg" exact="infective" post="dose FBS fetal bovine serum GAP good agricultural practice"/>
 <result pre="chromatography PBS phosphate buffered saline RNA ribonucleic acid SARS severe" exact="acute" post="respiratory syndrome SFC supercritical fluid chromatography SPF specific pathogen"/>
 <result pre="PBS phosphate buffered saline RNA ribonucleic acid SARS severe acute" exact="respiratory" post="syndrome SFC supercritical fluid chromatography SPF specific pathogen free"/>
 <result pre="phosphate buffered saline RNA ribonucleic acid SARS severe acute respiratory" exact="syndrome" post="SFC supercritical fluid chromatography SPF specific pathogen free TCID50"/>
 <result pre="fluid chromatography SPF specific pathogen free TCID50 50% tissue culture" exact="infective" post="dose TPCK N-p-Tosyl-L-phenylalanine chloromethyl ketone 1 Introduction Influenza viruses"/>
 <result pre="cases globally (Courtin et al., 2017). Currently, therapeutic strategies to" exact="lower" post="the mortality rates mainly rely on vaccines and chemical"/>
 <result pre="al., 2017; Zarubaev et al., 2015). On the other side," exact="viral" post="resistance and adverse effects restrict the clinic application of"/>
 <result pre="and commercially important resources in the prevention and treatment of" exact="viral" post="infectious diseases, a growing number of which are accumulating"/>
 <result pre="commercially important resources in the prevention and treatment of viral" exact="infectious diseases," post="a growing number of which are accumulating evidence of"/>
 <result pre="papule caused by warm toxin, macula, scarlatina, mumps, swelling abscess," exact="erysipelas" post="and erysipelas facialis (Chinese Pharmacopoeia Commission, 2015). As officially"/>
 <result pre="by warm toxin, macula, scarlatina, mumps, swelling abscess, erysipelas and" exact="erysipelas" post="facialis (Chinese Pharmacopoeia Commission, 2015). As officially approved medicinal"/>
 <result pre="remedies in prevention and treatment against a wide range of" exact="viral" post="infections, such as seasonal epidemics, severe acute respiratory syndrome"/>
 <result pre="wide range of viral infections, such as seasonal epidemics, severe" exact="acute" post="respiratory syndrome (SARS) in 2003 and H1N1 flu outbreaks"/>
 <result pre="range of viral infections, such as seasonal epidemics, severe acute" exact="respiratory" post="syndrome (SARS) in 2003 and H1N1 flu outbreaks in"/>
 <result pre="of viral infections, such as seasonal epidemics, severe acute respiratory" exact="syndrome" post="(SARS) in 2003 and H1N1 flu outbreaks in 2009"/>
 <result pre="Isatidis Radix was found to be effective in clinic against" exact="infections" post="caused by influenza viruses with different strains and subtypes"/>
 <result pre="inoculated with influenza virus A/California/7/2009 (H1N1). The 50% tissue culture" exact="infective" post="dose (TCID50) determined according to the Reed-Muench method (Reed,"/>
 <result pre="104Â cells/well) for 24Â h. To identify the probably affected" exact="viral" post="life cycle, cells were treated with 100Â Î¼L of"/>
 <result pre="at 37Â Â°C with sample solutions for 2Â h before" exact="viral" post="adsorption. Then the cells were washed with PBS and"/>
 <result pre="inoculated with influenza virus strain A/California/7/2009 (H1N1). The 50% egg" exact="infective" post="dose (EID50) calculated using the Reed-Muench method (Reed, 1938)"/>
 <result pre="membrane was carefully moved to sides to pipette out the" exact="upper" post="allantoic fluid. After harvesting, the allantoic fluid was subjected"/>
 <result pre="a â€œ+â€� symbol. The highest dilution of virus that caused" exact="complete" post="hemagglutination was considered as the end-point in HA titration."/>
 <result pre="211 for virus replication by the HA assay. Each diluted" exact="viral" post="solution was mixed with an equal volume (25Â Î¼L)"/>
 <result pre="min, hemagglutination titer was determined. The highest dilution to cause" exact="complete" post="agglutination in the HA assay was 128, which was"/>
 <result pre="the hemagglutination titer (1:32) was used as the standardized hemagglutinin" exact="viral" post="solution. 1:1 to 1:128 dilutions of the 5Â mg/mL"/>
 <result pre="PBS, respectively. Equal volumes (25Â Î¼L) of the standardized hemagglutinin" exact="viral" post="solution and the sample solutions were mixed gently and"/>
 <result pre="temperature for 30Â min 25Â Î¼L of the standardized hemagglutinin" exact="viral" post="solution and PBS were used as the positive and"/>
 <result pre="investigated concentrations showed no influence on cell viability. The maximum" exact="non-toxic" post="dose of Isatidis Radix derived glucosinolate isomers and their"/>
 <result pre="cells were pre-treated with epiprogoitrin, progoitrin, epigoitrin and goitrin before" exact="viral" post="adsorption or the cells were treated with the components"/>
 <result pre="2-fold and added to the 96-well plate. The standardized hemagglutinin" exact="viral" post="solution was added to the 96-well plate. Then, 0.6%"/>
 <result pre="mortality in epidemics each year. Due to adverse effect and" exact="viral" post="resistance, development of novel natural anti-influenza drugs becomes necessary"/>
 <result pre="influenza and has been reported to show satisfactory efficacy on" exact="respiratory" post="viruses, but the mechanism remains unilluminated till now (Xu"/>
 <result pre="and to determine at which stage they act in the" exact="viral" post="replication cycle. The results indicated that the antiviral activity"/>
 <result pre="observations, the four components were all found to significantly reduce" exact="viral" post="titer in chicken embryos when mixed with virus before"/>
 <result pre="hemagglutinin (HA) and neuraminidase (NA) embedded in the lipid envelope." exact="Viral" post="adsorption to cells is the initial step of influenza"/>
 <result pre="as virus neutralizers, which associate with some component on the" exact="viral" post="envelope without interfering with viral adsorption or budding. Based"/>
 <result pre="with some component on the viral envelope without interfering with" exact="viral" post="adsorption or budding. Based on the IC50 values obtained"/>
 <result pre="effect on hemagglutinin and neuraminidase. Thus, the attachment to the" exact="viral" post="envelope without disturbing viral adsorption or budding to host"/>
 <result pre="neuraminidase. Thus, the attachment to the viral envelope without disturbing" exact="viral" post="adsorption or budding to host cells was suggested to"/>
 <result pre="components. Potential activity on other influenza virus targets like endonuclease," exact="viral" post="polymerase, nucleoprotein or M2 protein needs future exploration. With"/>
 <result pre="of China2015China Medical Science PressBeijing CorreiaV.SantosL.A.GiriaM.Almeida-SantosM.M.Rebelo-de-AndradeH.Influenza A(H1N1)pdm09 resistance and cross-decreased" exact="susceptibility to" post="oseltamivir and zanamivir antiviral drugsJ. Med. Virol.872015455625042157 CourtinN.FotsoA.F.FautradP.MasF.AlessiM.C.RiteauB.Antiviral activity"/>
 <result pre="antiviral resistance threatsJ. Infect. Dis.203201161021148489 HuangI.C.LiW.SuiJ.H.MarascoW.ChoeH.FarzanM.Influenza A virus neuraminidase limits" exact="viral" post="superinfectionJ. Virol.8220084834484318321971 KeL.J.WenT.BradshawJ.P.ZhouJ.W.RaoP.F.Antiviral decoction of Isatidis Radix (bÇŽn lÃ¡n"/>
 <result pre="of RANTES expression by indirubin in influenza virus-infected human bronchial" exact="epithelial" post="cellsBiochem. Pharmacol.67200416717414667939 NieL.X.DaiZ.MaS.C.Determination of epigoitrin and goitrin in Isatidis"/>
 <result pre="fractions from Radix Isatidis revealed a multiple-target synergy effect against" exact="respiratory" post="syncytial virus through RIG-I and MDA5 signaling pathways, a"/>
 <result pre="activity of Isatis Indigotica root-derived clemastanin B against human and" exact="avian influenza" post="A and B viruses in vitroInt. J. Mol. Med.2013"/>
</results>
